Fingerprint
Dive into the research topics where Dong-Wan Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials
Kim, D. H., Kim, M., Youk, J., Kim, T. M., Lee, G. W., Kim, S. H., Kim, Y. J., Kim, J. S., Hong, S. H., Ahn, M. S., Shin, S. H., Kim, D. W., Kim, J. H. & Keam, B., Mar 2026, In: Lung Cancer. 213, 108916.Research output: Contribution to journal › Article › peer-review
-
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
Besse, B., Lin, J. J., Bazhenova, L., Goto, K., de Langen, A. J., Kim, D. W., Wolf, J., Springfeld, C., Popat, S., Lim, D. W. T., Nagasaka, M., Hong, J. Y., Baik, C. S., Hervieu, A., Moreno, V., Yang, N., Kollengode, K., Yang, H., Xu, Y. & Calvet, C. Y. & 4 others, , Feb 2026, In: Nature Medicine. 32, 2, p. 682-689 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1-Positive Non−Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial
Ahn, B. C., Kim, Y. J., Lee, Y., Suh, K. J., Kim, S. H., Kim, D. W., Kim, T. M., Lee, K. H. & Han, J. Y., 15 Jan 2026, In: JAMA Oncology. 12, 1, p. 84-89 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study☆
Peters, S., Camidge, R., Dziadziuszko, R., Gadgeel, S., Shaw, A. T., Kim, D. W., Pérol, M., Rosell, D. R., Cheema, P., Wan-Teck Lim, D., Lin, J. J., Pavlakis, N., Ahn, J. S., Zhang, L., Henschel, V., Higgerson, A. A., McNally, V., Rooney, I., Scalori, A. & Smoljanovic, V. & 1 others, , Jan 2026, In: Annals of Oncology. 37, 1, p. 92-103 12 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer
Cho, B. C., Charoentum, C., Kim, D. W., Yang, C. T., Dziadziuszko, R., Geater, S. L., Mann, H., Afshar-Imani, B., Lyfar, P., Yang, J. C. H. & Patel, S. P., Jan 2026, In: Lung Cancer. 211, 108834.Research output: Contribution to journal › Article › peer-review
Open Access